HedgeChatter

  • Home /
  • Tag Archives

HALO

Halozyme’s Q4 Loss Wider-Than-Expected

moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click here to view […]

February 28, 2014 Bystocknews , Comments Off on Halozyme’s Q4 Loss Wider-Than-Expected read more

Halozyme Reports Fourth Quarter And Year End 2013 Financial Results

[PR Newswire] – SAN DIEGO, Feb. 27, 2014 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the fourth quarter and full year ended December 31, 2013. Financial highlights for … moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on Halozyme Reports Fourth Quarter And Year End 2013 Financial Results read more

Halozyme Therapeutics To Present At The Cowen And Company 34th Annual Healthcare Conference

[PR Newswire] – SAN DIEGO, Feb. 25, 2014 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Cowen and Company 34 th Annual Healthcare Conference in Boston, MA on Tuesday, March 4, 2014 … moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click […]

February 25, 2014 Bystocknews , Comments Off on Halozyme Therapeutics To Present At The Cowen And Company 34th Annual Healthcare Conference read more

Halozyme to Host Fourth Quarter and 2013 Year-End Financial Results Conference Call

[PR Newswire] – SAN DIEGO, Feb. 20, 2014 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the fourth quarter and full year 2013 on Thursday, February 27, … moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click here to […]

February 20, 2014 Bystocknews , Comments Off on Halozyme to Host Fourth Quarter and 2013 Year-End Financial Results Conference Call read more

PropThink: Peregrine Shares Continue to Bleed, Sticking Around Could Hurt Worse

[ACN Newswire] – By David MoskowitzPeregrine Pharmaceuticals (NASDAQ:PPHM) opened down in early trading, as investors are still getting over the shock of the favorable clinical trial results for bavituximab reported last … moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboard […]

October 1, 2012 Bystocknews , Comments Off on PropThink: Peregrine Shares Continue to Bleed, Sticking Around Could Hurt Worse read more